Opus Genetics, Inc.
IRD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $31,791 | $27,851 | $25,711 | $19,160 |
| - Cash | $30,321 | $50,501 | $42,634 | $24,534 |
| + Debt | $18,843 | $0 | $0 | $538 |
| Enterprise Value | $20,313 | -$22,650 | -$16,923 | -$4,836 |
| Revenue | $10,992 | $19,049 | $39,850 | $589 |
| % Growth | -42.3% | -52.2% | 6,665.7% | – |
| Gross Profit | $10,992 | $19,049 | $39,850 | $589 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$57,522 | -$9,968 | $18,216 | -$56,687 |
| % Margin | -523.3% | -52.3% | 45.7% | -9,624.3% |
| Net Income | -$57,532 | -$9,986 | $17,888 | -$56,693 |
| % Margin | -523.4% | -52.4% | 44.9% | -9,625.3% |
| EPS Diluted | -2.15 | -0.46 | 0.87 | -3.82 |
| % Growth | -367.4% | -152.9% | 122.8% | – |
| Operating Cash Flow | -$25,576 | -$1,112 | $14,314 | -$19,370 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$25,576 | -$1,112 | $14,314 | -$19,370 |